News

heart drugs with stethoscope

The approval, made as part of a special FDA pilot program, took just 50 days.

Thumbnail

An interventional cardiologist believes he was targeted and terminated for being outspoken about a series of incidents at his hospital. 

broken relationship broken contract

The cardiovascular care of thousands of Missouri patients is suddenly up in the air. The heart of the issue is a practice's alleged interest in opening up a new private equity-backed clinic.  

staffing skills job title promotion recognition leadership

In particular, rads working in breast imaging and pediatrics appear to notch the lowest rates of career advancement, experts write in Current Problems in Diagnostic Radiology

dollar money finance debt decrease

David M. Cutler, PhD, a noted researcher and professor, shared his thoughts on the specialty in an editorial published by JAMA Health Forum

Thumbnail

Lancaster Radiology Associates and Penn Medicine had together owned both the MRI Group and PET Partnership, operating six centers in the Keystone State. 

Thumbnail

Ohio Senate Bill 324 would exempt NPs and PAs from certain licensure requirements, allowing them to supervise X-ray machine operators. 

Thumbnail

True Definition DL was designed to help produce detailed, high resolution images without protocol or workflow adjustments.

radiology reporting EHR health record CDS AUC

The system uses color coded flags to alert general practitioners that a patient's imaging report contains "serious or unexpected” findings.

money business cash flow dollar

While Kardium raised $250 million in an oversubscribed funding round, Field Medical raised $35 million. Both companies are focused on designing and developing new pulsed field ablation technologies to help treat challenging arrhythmias. 

radiology trends x-ray imaging practice management

Generative artificial intelligence models have shown great potential for improving multiple aspects of the radiology field, but a new analysis cautions that they still require significant oversight. 

Johnson & Johnson MedTech Automated Impella Controller

Johnson & Johnson MedTech has received reports of its Automated Impella Controller failing to connect properly with Impella heart pumps. If this happens, the FDA warned, it may put patients at risk.

Around the web

The approval, made as part of a special FDA pilot program, took just 50 days.